Young Women’s Eggs: Elite and Ordinary
By Elizabeth Reis, Biopolitical Times guest contributor
| 09. 15. 2011
My college-age daughter can earn $50,000-$100,000 just for being smart, beautiful, tall, and a Harvard student. Yes, going to Harvard could actually pay off, even sooner than we might have imagined. $100,000 would go a long way toward paying her tuition and fees, a fact that she has pointed out to me many times. And all she would have to do is “donate” her eggs to an infertile couple willing to pay.
“Donate” is quite a misnomer. Young women are getting paid handsomely, though there is outrageous discrepancy between what are considered “elite” and more ordinary eggs. At the University of Oregon, where I teach, advertisements frequently appear in the student newspaper offering only $5000 for my students’ eggs. Still, many are tempted. I worry that young women are being unfairly lured by these exorbitant sums (even $5000 is a lot to a college student at a public university) to sign on to something that we can’t really be sure is safe in the long run.
One danger is ovarian hyperstimulation syndrome (OHSS), a potentially harmful condition caused by the...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...